Plinabulin
An investigational drug for cancer treatment
| Plinabulin | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Plinabulin is a novel small molecule under investigation for its potential use in cancer treatment. It is primarily being studied for its ability to enhance the effects of chemotherapy and to act as an immunomodulatory agent.
Mechanism of Action[edit | edit source]
Plinabulin functions by disrupting the microtubule network within cancer cells, which is crucial for cell division and mitosis. This disruption leads to apoptosis or programmed cell death of the cancer cells. Additionally, Plinabulin has been shown to have immunomodulatory effects, potentially enhancing the body's immune response against cancer cells.
Clinical Development[edit | edit source]
Plinabulin is currently undergoing clinical trials to evaluate its efficacy and safety in combination with other chemotherapy agents. It has shown promise in reducing neutropenia, a common side effect of chemotherapy characterized by low levels of neutrophils, which are a type of white blood cell important for fighting infections.
Potential Benefits[edit | edit source]
The use of Plinabulin in combination with chemotherapy may offer several benefits:
- Reduction in chemotherapy-induced neutropenia, thereby decreasing the risk of infections.
- Enhancement of the anti-tumor effects of chemotherapy.
- Potential to improve overall survival rates and quality of life for patients undergoing cancer treatment.
Side Effects[edit | edit source]
As with many investigational drugs, Plinabulin may have side effects. Commonly reported side effects include:
Future Directions[edit | edit source]
Research is ongoing to further understand the full potential of Plinabulin in cancer therapy. Studies are exploring its use in various types of cancer, including lung cancer, breast cancer, and colorectal cancer.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
